Page last updated: 2024-08-22

platinum and Hematologic Neoplasms

platinum has been researched along with Hematologic Neoplasms in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, X; Huang, X; Luo, Y; Wang, S; Yu, B; Yue, X; Zhou, J	1
Abedin, S; Guru Murthy, GS	1
Degos, L; Demetri, GD; Dicato, M; Glaspy, J	1

Reviews

1 review(s) available for platinum and Hematologic Neoplasms

Article	Year
Myeloid malignancies after treatment for solid tumours. Best practice & research. Clinical haematology, 2019, Volume: 32, Issue:1 Topics: Chemotherapy, Adjuvant; Female; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Humans; Male; Myeloproliferative Disorders; Neoplasms, Second Primary; Platinum; Risk Factors; Topoisomerase II Inhibitors	2019

Trials

1 trial(s) available for platinum and Hematologic Neoplasms

Article	Year
Comparable efficacy of epoetin alfa for anemic cancer patients receiving platinum- and nonplatinum-based chemotherapy: a retrospective subanalysis of two large, community-based trials. The oncologist, 2002, Volume: 7, Issue:2 Topics: Anemia; Blood Transfusion; Disease Progression; Dose-Response Relationship, Drug; Epoetin Alfa; Erythropoietin; Female; Follow-Up Studies; Hematinics; Hematologic Neoplasms; Hemoglobins; Humans; Male; Middle Aged; Neoplasms; Platinum; Predictive Value of Tests; Prognosis; Quality of Life; Recombinant Proteins; Retrospective Studies; Sensitivity and Specificity; Time Factors; Treatment Outcome	2002

Article

Year

Comparable efficacy of epoetin alfa for anemic cancer patients receiving platinum- and nonplatinum-based chemotherapy: a retrospective subanalysis of two large, community-based trials.

The oncologist, 2002, Volume: 7, Issue:2

Topics: Anemia; Blood Transfusion; Disease Progression; Dose-Response Relationship, Drug; Epoetin Alfa; Erythropoietin; Female; Follow-Up Studies; Hematinics; Hematologic Neoplasms; Hemoglobins; Humans; Male; Middle Aged; Neoplasms; Platinum; Predictive Value of Tests; Prognosis; Quality of Life; Recombinant Proteins; Retrospective Studies; Sensitivity and Specificity; Time Factors; Treatment Outcome

2002

Other Studies

1 other study(ies) available for platinum and Hematologic Neoplasms

Article	Year
Selective bio-labeling and induced apoptosis of hematopoietic cancer cells using dual-functional polyethylenimine-caged platinum nanoclusters. Biochemical and biophysical research communications, 2018, 09-10, Volume: 503, Issue:3 Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Drug Screening Assays, Antitumor; Hematologic Neoplasms; Humans; Metal Nanoparticles; Organoplatinum Compounds; Particle Size; Platinum; Polyethyleneimine; Tumor Cells, Cultured	2018

Article

Year

Selective bio-labeling and induced apoptosis of hematopoietic cancer cells using dual-functional polyethylenimine-caged platinum nanoclusters.

Biochemical and biophysical research communications, 2018, 09-10, Volume: 503, Issue:3

Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Drug Screening Assays, Antitumor; Hematologic Neoplasms; Humans; Metal Nanoparticles; Organoplatinum Compounds; Particle Size; Platinum; Polyethyleneimine; Tumor Cells, Cultured

2018